Wednesday, 19 April, 13:30-14:30 - Abbott Point of Care Division
ACT testing -When there’s no room for doubt
Chair: Prof. Florian Falter (UK)
Wednesday, 19 April, 13:30-14:30 - Edwards Lifesciences
PAC Technology – Past, Present and Future
Moderator: Prof. Dr. Steffen Rex (Leuven, Belgium)
Thursday, 20 April, 13:30-14:30 - Medtronic
INTRA-PROCEDURAL MANAGEMENT TO IMPROVE PATIENT OUTCOMES
Thursday, 20 April, 13:30-14:30 - Orion Corp.
Pre-, Peri-, and Post-operative use of levosimendan: the LEVO-CTS, CHEETAH and LICORN trials in the eye of clinical practice
Chairs: Matthias Heringlake (Germany), Fabio Guarracino (Italy), Sven-Erik Ricksten (Sweden)
Levosimendan, a cardioprotective inodilator, was developed as a treatment for acute heart failure and is used. In this symposium, the investigators of three recent clinical trials on levosimendan in the cardiac surgery settings will describe and discuss their results. Prof.Cholley (Paris, France) will present the LICORN trial of peri-operative use of levosimendan, Prof. Landoni (Milan, Italy) the CHEETAH trial of post-operative use of levosimendan, and Prof. Heringlake (Lübeck, Germany) the LEVO-CTS trial on pre-operative use of levosimendan. Prof. Guarracino (Pisa, Italy) and Ricksten (Gotenburg, Sweden) will join the discussion in a final panel debate.
Friday, 21 April, 13:30-14:30 - CSL Behring
Bleeding: a challenge in cardiovascular surgery
Chairs: Donat Spahn (Switzerland), Kai Zacharowski (Germany)
Friday, 21 April, 13:30 - 14:30 Nordic Pharma
WHAT PLACE DOES APROTININ HAVE IN FUTURE CLINICAL PRACTICE?
Chair: Prof. Christian von Heymann (Germany)